Tuesday, September 4, 2007

ESC Congress - News - Ebbing hotline III homcysteine and CVD risk

ESC Congress 2007 Press Releases - Ebbing hotline III homcysteine and CVD risk

Conclusion: Our findings are in concordance with, and add further evidence to, previous trials that have failed to prove that homocysteine-lowering intervention with folate supplementation reduces risk of death or progression of cardiovascular disease in patients with established cardiovascular disease. Furthermore, there were no effects of vitamin B6 treatment. At this time, B-vitamin supplementation is not justified as secondary prevention in cardiovascular disease.

No comments: